No Data
No Data
We Think 10x Genomics (NASDAQ:TXG) Can Easily Afford To Drive Business Growth
Shareholders in 10x Genomics (NASDAQ:TXG) Have Lost 87%, as Stock Drops 7.2% This Past Week
RBC Capital Markets Change Price Targets for Certain North American Precious Metals Equities
Stock Selloff Slashes Needed-market Cap for New Russell 2000 Additions: Stephens
Citigroup Maintains Buy on 10x Genomics, Lowers Price Target to $15
10x Genomics Analyst Ratings